HAB Pharmaceuticals – potency remedy | Buy in Ukraine with delivery

What is HAB Pharmaceuticals?

HAB Pharmaceuticals is a medicinal drug that belongs to the category of combined pharmacological agents with pronounced therapeutic activity. The manufacturer of the drug is HAB Pharmaceuticals, a pharmaceutical company specializing in the development and production of high-quality medicines in accordance with international GMP standards. The main purpose of the drug is the correction of pathological conditions associated with inflammatory processes, pain syndrome, and functional activity disorders of certain body systems. The release form of HAB Pharmaceuticals includes a tablet dosage form, which ensures convenient oral administration and dosing accuracy. The drug is dispensed by a doctor's prescription, as it requires an individual selection of a therapeutic regimen taking into account the clinical picture.

The pharmacological group of HAB Pharmaceuticals is determined by its active substance, which has a systemic effect on the patient's body. The drug demonstrates high bioavailability when taken orally, allowing it to achieve a stable therapeutic concentration in blood plasma within a relatively short period of time. The manufacturer of HAB Pharmaceuticals pays special attention to quality control at every stage of the production cycle — from the synthesis of the active substance to the packaging of the finished product. Thanks to this, the drug is characterized by a predictable pharmacokinetic profile and a minimal risk of impurities. Clinical studies confirm the efficacy and safety of the drug provided that the recommended doses are observed.

The therapeutic value of HAB Pharmaceuticals is due to a combination of rapid onset of effect and long-term supportive action. The drug is metabolized mainly in the liver, and the excretion of metabolites is carried out by the kidneys, which should be taken into account by patients with impaired function of these organs. HAB Pharmaceuticals is available in blisters that provide protection from moisture and light, maintaining the stability of the active components throughout the shelf life. The original packaging contains detailed instructions for use, developed in accordance with the requirements of regulatory authorities. Before starting therapy, a consultation with a doctor is mandatory, as self-medication can lead to adverse consequences.

What is HAB Pharmaceuticals prescribed for?

The main indications for the use of HAB Pharmaceuticals are conditions accompanied by acute or chronic pain syndrome of various origins. The drug effectively eliminates pain sensations in diseases of the musculoskeletal system, particularly in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The analgesic effect develops due to the inhibition of the synthesis of prostaglandins — mediators of inflammation and pain in peripheral tissues. A clinically significant reduction in pain intensity is observed within 30–60 minutes after taking a single dose. The duration of the analgesic effect allows using the drug two to three times a day without the risk of accumulation.

HAB Pharmaceuticals is also prescribed for the treatment of inflammatory processes occurring in soft tissues, joints, and internal organs. The drug reduces the severity of edema, redness, and local fever in the affected area, helping restore function. The anti-inflammatory effect is achieved by blocking cyclooxygenase of the second type, which provides a selective effect on the pathological process without significant suppression of the physiological functions of the gastrointestinal tract. Thanks to this, the drug can be used for long courses under medical supervision. Patients with chronic inflammatory diseases report an improvement in quality of life after the first week of therapy.

An additional indication for the use of HAB Pharmaceuticals is the symptomatic treatment of febrile conditions accompanying infectious and inflammatory diseases. The drug has an antipyretic effect, normalizing body temperature without a sharp decrease and the development of collaptoid reactions. The antipyretic effect is realized through influence on the thermoregulation center in the hypothalamus, which ensures the physiological restoration of heat balance. HAB Pharmaceuticals can be prescribed as part of complex therapy for acute respiratory viral infections, influenza, and other conditions accompanied by fever. However, the drug does not affect the etiologic factor of the disease, so it requires combination with antiviral or antibacterial agents as prescribed by a doctor.

Composition and active components of HAB Pharmaceuticals

The composition of HAB Pharmaceuticals includes an active pharmaceutical substance belonging to the class of nonsteroidal anti-inflammatory drugs with selective action on cyclooxygenase-2. This substance provides the main therapeutic effect of the drug, combining pronounced anti-inflammatory, analgesic, and antipyretic activity. The mechanism of action is to block the enzyme responsible for converting arachidonic acid into prostaglandins, which play a key role in the development of an inflammatory reaction. The selectivity of action reduces the risk of damage to the gastric mucosa compared to non-selective drugs of this group. The concentration of the active substance in one tablet is selected in such a way as to ensure an optimal balance between efficacy and safety.

Excipients of HAB Pharmaceuticals act as stabilizers, fillers, and substances that provide proper technological properties of the tablet mass. The composition includes microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, magnesium stearate, and colloidal silicon dioxide. Each of these components has undergone a thorough check for safety and compatibility with the active substance. Lactose monohydrate ensures the structural integrity of the tablet, and croscarmellose sodium promotes rapid disintegration of the dosage form in the gastrointestinal tract. Magnesium stearate is used as a lubricating agent that prevents the tablet mass from sticking to pressing equipment.

The pharmaceutical company HAB Pharmaceuticals uses modern manufacturing technologies that guarantee an even distribution of the active substance in each tablet. This ensures dosing accuracy and predictability of therapeutic response in various patient groups. Quality control at the release stage of each batch includes checking disintegration, dissolution, dosage uniformity, and microbiological purity. The drug does not contain dyes, flavorings, or preservatives, which reduces the risk of allergic reactions. The full composition is specified in the official instructions for HAB Pharmaceuticals.

Dosage of HAB Pharmaceuticals

The recommended dose of HAB Pharmaceuticals for adult patients is one tablet once or twice a day, depending on the severity of clinical manifestations. The maximum daily dose should not exceed two tablets, as a further increase in dosage does not lead to an increase in the therapeutic effect, but increases the risk of side effects. The duration of the treatment course is determined by the doctor individually, but 5–7 days are usually sufficient for symptomatic therapy of acute pain. In chronic inflammatory joint diseases, the course may be extended to several weeks or months, provided that the patient's condition is regularly monitored. Exceeding recommended doses is strictly prohibited.

For elderly patients, dose adjustment of HAB Pharmaceuticals is usually not required, but it is recommended to start therapy with the minimum effective dose. This is due to an age-related decrease in kidney and liver function, which can slow down the excretion of the drug from the body. Patients with moderate renal impairment should use the drug with caution and under the control of laboratory parameters. In severe renal failure, the use of HAB Pharmaceuticals is contraindicated. Dosage for patients with mild to moderate hepatic impairment may require individual adjustment.

If a regular dose is missed, the next one should not be doubled, as this increases the risk of toxic effects. It is necessary to take the drug as soon as the patient remembers the omission, if there is a sufficient interval of time left before the next dose. Otherwise, the missed dose should be skipped and the regular schedule continued. The duration of continuous use of HAB Pharmaceuticals without consulting a doctor should not exceed 10 days. In the absence of improvement in condition during this period, it is necessary to seek medical help to review the therapeutic strategy.

How to take HAB Pharmaceuticals correctly?

HAB Pharmaceuticals should be taken orally with a sufficient amount of water — at least 150–200 ml. The tablet is not recommended to be chewed, crushed, or divided, as this may break the integrity of the enteric coating and alter the pharmacokinetics of the drug. The optimal time for administration is during or immediately after meals, which reduces the irritating effect on the gastric mucosa. Regularity of intake is essential for maintaining a stable therapeutic concentration of the active substance in the blood. It is advisable to take the drug at the same time of day, which facilitates habit formation and reduces the risk of missing a dose.

During the course of treatment with HAB Pharmaceuticals, it is recommended to abstain from drinking alcoholic beverages, as ethanol can enhance the irritating effect on the gastrointestinal tract. Patients with chronic diseases of the stomach and duodenum may be recommended an additional prescription of gastroprotective agents. If epigastric pain, nausea, or dyspeptic symptoms appear, a doctor should be informed to adjust therapy. The drug should not be taken on an empty stomach, especially in patients with hypersensitivity of the digestive tract mucosa. Compliance with these recommendations allows minimizing the risk of adverse reactions from the gastrointestinal system.

Individual response of the body to HAB Pharmaceuticals may vary depending on age, sex, concomitant diseases, and genetic characteristics of metabolism. Therefore, the first days of therapy require special attention to well-being and timely informing the doctor about any unusual symptoms. Patients driving vehicles or operating machinery should consider the possibility of dizziness or drowsiness at the beginning of treatment. If severe side effects develop, the drug should be discontinued and medical advice sought. Unauthorized changes in dose or frequency of administration are unacceptable without agreement with a doctor.

Side effects of HAB Pharmaceuticals

The most common side effects of HAB Pharmaceuticals are gastrointestinal disorders manifested by dyspepsia, nausea, abdominal pain, and diarrhea. These symptoms are usually transient and disappear after the body adapts to the drug or the dose is reduced. Less commonly, erosive and ulcerative lesions of the gastric and duodenal mucosa are observed, especially in patients with risk factors. Risk factors include advanced age, concomitant use of glucocorticosteroids, anticoagulants, and a history of peptic ulcer disease. To prevent complications, the doctor may prescribe an additional course of proton pump inhibitors.

From the cardiovascular system, an increase in blood pressure, fluid retention in the body, and the appearance of peripheral edema are possible. Patients with arterial hypertension and chronic heart failure require regular monitoring of hemodynamic parameters during therapy with HAB Pharmaceuticals. Neurological side effects include headache, dizziness, drowsiness, or insomnia, which are usually mild in severity. Allergic reactions in the form of skin rash, itching, and urticaria occur rarely, but require immediate discontinuation of the drug. In case of angioedema or an anaphylactic reaction, emergency medical assistance is required.

Rare but serious side effects of HAB Pharmaceuticals are impaired liver and kidney function, manifested by increased levels of transaminases, creatinine, and urea in the blood. Patients with chronic diseases of these organs are recommended periodic laboratory monitoring during a long course of therapy. If jaundice, dark urine, significant weakness, or a decrease in urine output appears, you should consult a doctor immediately. Individual body reactions may include other adverse events not listed in the instructions, which should be reported to a medical professional. Timely detection and correction of side effects allows continuing therapy with minimal health risk.

Contraindications of HAB Pharmaceuticals

Absolute contraindications to the use of HAB Pharmaceuticals are hypersensitivity to the active substance or any excipient of the drug. A history of bronchospasm, urticaria, or allergic rhinitis after taking acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs also excludes the possibility of prescribing this drug. Active peptic ulcer of the stomach or duodenum, gastrointestinal bleeding, or perforation is a direct contraindication due to the risk of exacerbation of these conditions. Severe heart failure, severe hepatic, and renal failure make safe use of the drug impossible. The third trimester of pregnancy is an absolute contraindication due to the risk of premature closure of the ductus arteriosus in the fetus.

Relative contraindications requiring special caution are peptic ulcer disease in remission, inflammatory bowel diseases, and Helicobacter pylori infection. Patients with bronchial asthma can use HAB Pharmaceuticals only under close medical supervision due to the risk of bronchospasm. Blood clotting disorders and concomitant use of anticoagulants require regular monitoring of coagulogram parameters. In the first and second trimesters of pregnancy, the drug can be prescribed only in case of extreme necessity, when the expected benefit to the mother outweighs the potential risk to the fetus. Use during breastfeeding is not recommended, as the active substance passes into breast milk.

Children under 18 years of age are a contraindication for the use of HAB Pharmaceuticals due to the lack of sufficient data on safety and efficacy in this age group. The drug is prescribed to elderly patients with caution, starting with the minimum effective dose and providing regular medical supervision. Patients with hereditary lactose intolerance should take into account the presence of lactose monohydrate in the composition of the drug. Before starting therapy, it is necessary to inform the doctor about all existing diseases and medications taken constantly. Only a doctor can assess the ratio of benefit and risk and decide on the appropriateness of prescribing HAB Pharmaceuticals.

Interaction of HAB Pharmaceuticals with other drugs and alcohol

HAB Pharmaceuticals may interact with other medicinal products, altering their efficacy or increasing the risk of side effects. Concomitant use with anticoagulants, such as warfarin, increases the risk of bleeding, therefore requiring regular monitoring of the international normalized ratio. Combination with other nonsteroidal anti-inflammatory drugs or glucocorticosteroids significantly increases the likelihood of gastrointestinal damage. The drug may reduce the effectiveness of diuretics and antihypertensive agents, requiring adjustment of their doses. Simultaneous administration with lithium preparations, methotrexate, or cyclosporine increases their toxicity due to reduced renal clearance.

Alcohol consumption during therapy with HAB Pharmaceuticals is strictly not recommended, as ethanol enhances the irritating effect on the gastric mucosa and increases the risk of gastrointestinal bleeding. In addition, combining alcohol with the drug increases the burden on the liver, which can lead to toxic damage to hepatocytes. Patients driving vehicles should take into account that HAB Pharmaceuticals can cause dizziness and slowing of psychomotor reactions, especially at the beginning of treatment. If these symptoms appear, you should refrain from driving and performing work requiring increased concentration of attention. Any doubts about drug compatibility should be discussed with a doctor or pharmacist.

Where to buy HAB Pharmaceuticals in Ukraine

HAB Pharmaceuticals is available for purchase in pharmacy institutions of Ukraine with a doctor's prescription. The drug is presented in many pharmacy chains, which provides convenient search for patients in different regions of the country. The possibility of online booking allows checking the availability of the drug in a specific pharmacy in advance and reserving it for subsequent purchase. The cost of HAB Pharmaceuticals may vary depending on the pharmacy chain and region, so it is advisable to compare prices before buying. Patients should pay attention to the integrity of the packaging and the shelf life of the drug.

HAB Pharmaceuticals must be stored in its original packaging at a temperature not exceeding 25 degrees Celsius in a place protected from light and moisture. The drug should be kept out of the reach of children to prevent accidental ingestion. The shelf life is usually three years from the date of manufacture, after which the use of the drug is prohibited. Before purchasing, it is recommended to check for the presence of a protective holographic marking confirming the originality of HAB Pharmaceuticals products. If any questions arise regarding the use of the drug, it is necessary to consult a doctor or pharmacist for qualified advice.